Correspondingly, elevated serum FGF21 has been detected in humans with mitochondrial respiratory chain defects in muscle, suggesting its potential utility as a biomarker for diagnosing mitochondrial myopathies (Suomalainen et al., 2011). This evidence concerns the gene FGF21 and Mitochondrial myopathy.